Filing Details
- Accession Number:
- 0001850902-22-000027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-02 16:34:32
- Reporting Period:
- 2022-09-01
- Accepted Time:
- 2022-09-02 16:34:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1850902 | Alpha Teknova Inc. | TKNO | In Vitro & In Vivo Diagnostic Substances (2835) | 943368109 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1861091 | Matthew Lowell | C/O Alpha Teknova, Inc. 2451 Bert Drive Hollister CA 95023 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-01 | 10,000 | $4.61 | 20,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $4.32 to $4.88, inclusive. The reporting person undertakes to provide to Alpha Teknova, Inc. (the Company), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this Footnote 1.
Billionaire Hedge Funds
